Celldex Therapeutics, Inc. Gains 35.24%
Fri 21 Feb 20 at 05:30 PM
Celldex Therapeutics, Inc. (CLDX:NASDAQ) soared at $3.07, a gain of 35.2%. From Thu 30 Jan 20, the stock recorded 42.86% Up Days and 26.67% Green Days
The share price of the company has been moving sideways in recent weeks.
About Celldex Therapeutics, Inc. (CLDX:NASDAQ)
Celldex Therapeutics Inc is a biopharmaceutical company. The Company is engaged in the development and commercialization of immunotherapy technologies for the treatment of cancer and other difficult-to-treat diseases.
Top 10 Gainers:
- Tocagen Inc. (TOCA:NASDAQ), 111.11%
- Trans World Entertainment Corporation (TWMC:NASDAQ), 50.86%
- Unit Corporation (UNT:NYSE), 37.02%
- Celldex Therapeutics, Inc. (CLDX:NASDAQ), 35.24%
- Ducommun Incorporated (DCO:NYSE), 33.09%
- Eldorado Gold Corporation (EGO:NYSE), 32.05%
- Avadel Pharmaceuticals plc (AVDL:NASDAQ), 32.02%
- Genprex, Inc. (GNPX:NASDAQ), 21.69%
- Kirkland's, Inc. (KIRK:NASDAQ), 20.66%
- IGM Biosciences, Inc. (IGMS:NASDAQ), 20.25%